BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19932736)

  • 1. Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro.
    Horvath G; Mark L; Brubel R; Szakaly P; Racz B; Kiss P; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Shintani N; Furjes G; Nemeth J; Reglodi D
    Neurosci Lett; 2010 Jan; 469(1):70-4. PubMed ID: 19932736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) show increased susceptibility to in vivo renal ischemia/reperfusion injury.
    Szakaly P; Laszlo E; Kovacs K; Racz B; Horvath G; Ferencz A; Lubics A; Kiss P; Tamas A; Brubel R; Opper B; Baba A; Hashimoto H; Farkas J; Matkovits A; Magyarlaki T; Helyes Z; Reglodi D
    Neuropeptides; 2011 Apr; 45(2):113-21. PubMed ID: 21211837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of pituitary adenylate cyclase activating polypeptide and its type I receptor in the rat kidney.
    Brubel R; Horvath G; Reglodi D; Lubics A; Tamas A; Kiss P; Laszlo E; Nemeth J; Mark L; Szakaly P
    Transplant Proc; 2011 May; 43(4):1297-9. PubMed ID: 21620115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis.
    Rácz B; Gasz B; Borsiczky B; Gallyas F; Tamás A; Józsa R; Lubics A; Kiss P; Roth E; Ferencz A; Tóth G; Hegyi O; Wittmann I; Lengvári I; Somogyvári-Vigh A; Reglodi D
    Gen Comp Endocrinol; 2007; 153(1-3):115-23. PubMed ID: 17270184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis.
    Gasz B; Rácz B; Roth E; Borsiczky B; Ferencz A; Tamás A; Cserepes B; Lubics A; Gallyas F; Tóth G; Lengvári I; Reglodi D
    Peptides; 2006 Jan; 27(1):87-94. PubMed ID: 16095757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice deficient in neuropeptide PACAP demonstrate increased sensitivity to in vitro kidney hypoxia.
    Horvath G; Racz B; Szakaly P; Kiss P; Laszlo E; Hau L; Tamas A; Helyes Z; Lubics A; Hashimoto H; Baba A; Reglodi D
    Transplant Proc; 2010; 42(6):2293-5. PubMed ID: 20692466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study.
    Racz B; Horvath G; Reglodi D; Gasz B; Kiss P; Gallyas F; Sumegi B; Toth G; Nemeth A; Lubics A; Tamas A
    Regul Pept; 2010 Feb; 160(1-3):91-8. PubMed ID: 19969027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of PACAP on the oxidative stress-induced cell death in chicken pinealocytes is influenced by the phase of the circadian clock.
    Horvath G; Reglodi D; Opper B; Brubel R; Tamas A; Kiss P; Toth G; Csernus V; Matkovits A; Racz B
    Neurosci Lett; 2010 Oct; 484(2):148-52. PubMed ID: 20727939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis.
    Masmoudi-Kouki O; Douiri S; Hamdi Y; Kaddour H; Bahdoudi S; Vaudry D; Basille M; Leprince J; Fournier A; Vaudry H; Tonon MC; Amri M
    J Neurochem; 2011 May; 117(3):403-11. PubMed ID: 21244427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of autonomic nerve activities by central pituitary adenylate cyclase-activating polypeptide.
    Tanida M; Shintani N; Morita Y; Tsukiyama N; Hatanaka M; Hashimoto H; Sawai H; Baba A; Nagai K
    Regul Pept; 2010 Apr; 161(1-3):73-80. PubMed ID: 20171991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pituitary adenylate cyclase activating polypeptide on the survival and signal transduction pathways in human choriocarcinoma cells.
    Boronkai A; Brubel R; Racz B; Tamas A; Kiss P; Horvath G; Lubics A; Szigeti A; Bellyei S; Toth G; Lakatos A; Reglodi D
    Ann N Y Acad Sci; 2009 Apr; 1163():353-7. PubMed ID: 19456358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.
    Hautmann M; Friis UG; Desch M; Todorov V; Castrop H; Segerer F; Otto C; Schütz G; Schweda F
    J Am Soc Nephrol; 2007 Apr; 18(4):1150-6. PubMed ID: 17360952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in pituitary adenylate cyclase-activating polypeptide following renal ischemia-reperfusion in rats.
    Szakaly P; Horvath G; Kiss P; Laszlo E; Farkas J; Furjes G; Nemeth J; Reglodi D
    Transplant Proc; 2010; 42(6):2283-6. PubMed ID: 20692463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
    Girard BA; Lelievre V; Braas KM; Razinia T; Vizzard MA; Ioffe Y; El Meskini R; Ronnett GV; Waschek JA; May V
    J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury.
    Li M; Balamuthusamy S; Khan AM; Maderdrut JL; Simon EE; Batuman V
    Peptides; 2010 Apr; 31(4):592-602. PubMed ID: 20034524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice.
    Laszlo E; Varga A; Kovacs K; Jancso G; Kiss P; Tamas A; Szakaly P; Fulop B; Reglodi D
    Transplant Proc; 2015 Sep; 47(7):2210-5. PubMed ID: 26361682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage.
    Stumm R; Kolodziej A; Prinz V; Endres M; Wu DF; Höllt V
    J Neurochem; 2007 Nov; 103(4):1666-81. PubMed ID: 17868305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cerebellar development in mice lacking pituitary adenylate cyclase-activating polypeptide.
    Allais A; Burel D; Isaac ER; Gray SL; Basille M; Ravni A; Sherwood NM; Vaudry H; Gonzalez BJ
    Eur J Neurosci; 2007 May; 25(9):2604-18. PubMed ID: 17561835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice.
    Hashimoto H; Shintani N; Baba A
    Ann N Y Acad Sci; 2006 Jul; 1070():75-89. PubMed ID: 16888150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.